NetBio Announces its DNAscan System is the First and Only Rapid DNA Product to Earn NDIS Approval from the FBI
WALTHAM, MA– April 7, 2016
Approval represents major step toward widespread adoption of Rapid DNA analysis with potential to transform the use of DNA in criminal justice
Ray Locker and Kendall Breitman, USA TODAY
2:57 p.m. EST January 27, 2014
Researchers are closing in on the final steps of a new system to analyze human DNA in 90 minutes instead of the two to three weeks it now takes, according to interviews with Pentagon and industry officials.
Technical evaluation of Rapid DNA technology is a fundamental step towards responsible adoption by law enforcement agencies
8:22 a.m. EDT May 7, 2014
CHALFONT ST. GILES, England & WALTHAM, Mass.--(BUSINESS WIRE)--GE Healthcare Life Sciences, (NYSE: GE), and NetBio named today several of the laboratories participating in the recently announced comprehensive developmental validation of DNAscan™ Rapid DNA Analysis™ System. Leading international and US accredited NDIS participating forensic laboratories are independently evaluating the overall system from “swab-in to profile-out”, including the on-board Expert System software which uses automated data interpretation to eliminate the need for human review.
Selden, et al. (2013). Rapid Focused Sequencing: A Multiplexed Assay for Simultaneous Detection and Strain Typing of Bacillus anthracis, Francisella tularensis, and Yersinia pestis. PLoS ONE 8(2): e56093. doi:10.1371/ journal.pone.0056093. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0056093
Selden, et al. (2012). A Multiplexed Microfluidic PCR Assay for Sensitive and Specific Point-of-Care Detection of Chlamydia trachomatis. PLoS ONE 7(12): e51685. doi:10.1371/ journal.pone.0051685. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0051685